Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to 1)to determine if it is better to treat all early RA patients
with methotrexate in combination with hydroxychloroquine plus sulfasalazine or in combination
with etanercept or reserve this treatment for patients who do not appropriately respond to
methotrexate alone and 2) to determine which combination of methotrexate therapy is better